A pilot applicant preparing for a Class 3 medical certification appointment has raised a common but consequential question about FAA MedXpress disclosure: whether a benign eyelid growth (identified pathologically as a pyogenic granuloma) removed roughly a year prior needs to be reported, and whether the AME encounter should proceed as scheduled or be postponed pending additional documentation. The growth was excised in a brief outpatient procedure by an ophthalmologist, confirmed benign via pathology, never affected vision, and has fully healed. The applicant answered "No" to the eye-related question on MedXpress, reasoning that the lesion was on the eyelid rather than the eye itself and had no functional impact. This scenario, while seemingly minor from a clinical standpoint, touches on one of the most consistently misunderstood aspects of the FAA medical certification process: what counts as a "condition" requiring disclosure.
The core issue for working pilots is that MedXpress disclosure requirements are broader than most applicants assume. The FAA's eye-related question on the form is not limited to conditions affecting visual acuity or ocular function—it generally captures any eye, eyelid, or adnexal surgery or diagnosed condition, regardless of whether it impaired vision. A benign eyelid growth that was surgically removed and sent to pathology arguably falls under "eye history" reporting requirements, even though the applicant's instinct that it was a non-issue clinically is likely correct. This is a critical distinction pilots must internalize: the FAA cares about complete and accurate disclosure as much as it cares about the underlying medical significance of a condition. Inaccurate or incomplete MedXpress answers—even when well-intentioned and involving trivial conditions—can trigger deferrals, HIMS involvement, or in worse cases, allegations of falsification under 18 U.S.C. § 1001, which carries far more serious certification consequences than the original medical issue ever would.
For AMEs, a benign eyelid lesion with a clean pathology report and full resolution is almost always an easy Fast Track or same-day issuance item, provided it's disclosed and briefly documented. The safer and more professional path, which several experienced voices in aviation medical forums consistently recommend, is proactive disclosure at the appointment: bring whatever documentation exists (the pathology report if available, or a brief note from the ophthalmologist) and let the AME make the call in real time rather than trying to pre-adjudicate the MedXpress question alone. Canceling the appointment is rarely necessary for something this benign, but walking in having already answered "No" to a question that likely should have been "Yes" creates unnecessary risk. AMEs deal with this exact pattern regularly and can usually amend the application or annotate the record during the visit itself.
More broadly, this case reflects a recurring theme in pilot medical certification: the disclosure threshold is intentionally low, and the FAA's electronic system creates a paper trail that didn't exist in the same way decades ago. Minor derm and eye procedures, once handled with a verbal mention to the AME, now require careful attention to how MedXpress questions are worded. This trend has pushed pilots—especially those pursuing Class 1 and 2 certificates for professional pathways—toward a more conservative, "when in doubt, disclose and document" approach, often with guidance from AME consultants or organizations like AOPA's Pilot Protection Services. As medical scrutiny and cross-referencing of civilian health records with FAA databases continues to tighten, the operational lesson for all pilots, student through ATP, is the same: treat MedXpress as a legal document first and a medical form second, and resolve ambiguity before the appointment rather than during it.